- GlobeNewswire•4 days ago
Progenics Pharmaceuticals Announces Presentations at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
NEW YORK, April 20, 2017-- Progenics Pharmaceuticals, Inc., an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that data from a prospective ...
- TheStreet.com•22 days ago
I've learned that emotions have little use at a poker table; they don't in the stock market, either.
- GlobeNewswire•25 days ago
NEW YORK, March 30, 2017-- Progenics Pharmaceuticals, Inc., an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that Mark R. Baker, ...
PGNX : Summary for Progenics Pharmaceuticals Inc. - Yahoo Finance
Progenics Pharmaceuticals, Inc. (PGNX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||5.14 x 100|
|Ask||8.13 x 100|
|Day's Range||7.65 - 7.98|
|52 Week Range||4.00 - 11.72|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||51.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|